Shah Shweta, Joseph Catherine, Srivaths Poyyapakkam
Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Pediatr Nephrol. 2022 Feb;37(2):315-328. doi: 10.1007/s00467-021-05093-w. Epub 2021 May 15.
Therapeutic apheresis utilizes apheresis procedures in the treatment of a variety of conditions including kidney disease. Therapeutic plasma exchange (TPE) is the most common modality employed with the rationale of rapid reduction of a pathogenic substance distributed primarily in the intravascular compartment; however other techniques which adsorb such pathogenic substances or alter the immune profile have been utilized in diseases affecting native and transplanted kidneys. This article discusses the modalities and technical details of therapeutic apheresis and summarizes its role in individual diseases affecting the kidney. Complications related to pediatric apheresis procedures and specifically related to apheresis in kidney disease are also discussed. Though therapeutic apheresis modalities are employed frequently in children with kidney disease, most experiences are extrapolated from adult studies. International and national registries need to be established to elucidate the role of apheresis modalities in children with kidney disease.
治疗性血液成分单采术利用血液成分单采程序来治疗包括肾脏疾病在内的多种病症。治疗性血浆置换(TPE)是最常用的方式,其原理是迅速减少主要分布在血管内 compartment 的致病物质;然而,其他吸附此类致病物质或改变免疫谱的技术已被用于影响天然肾脏和移植肾脏的疾病。本文讨论了治疗性血液成分单采术的方式和技术细节,并总结了其在影响肾脏的个体疾病中的作用。还讨论了与儿科血液成分单采程序相关的并发症,特别是与肾脏疾病中的血液成分单采相关的并发症。尽管治疗性血液成分单采术方式在患有肾脏疾病的儿童中经常使用,但大多数经验是从成人研究中推断出来的。需要建立国际和国家登记处,以阐明血液成分单采术方式在患有肾脏疾病的儿童中的作用。